Neuropeptidni Y receptor Y1
edit |
Neuropeptidni Y receptor Y1 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifikatori | |||||||||||
Simboli | NPY1R; NPYR | ||||||||||
Vanjski ID | OMIM: 162641 MGI: 104963 HomoloGene: 700 IUPHAR: Y1 GeneCards: NPY1R Gene | ||||||||||
| |||||||||||
Pregled RNK izražavanja | |||||||||||
![]() | |||||||||||
podaci | |||||||||||
Ortolozi | |||||||||||
Vrsta | Čovek | Miš | |||||||||
Entrez | 4886 | 18166 | |||||||||
Ensembl | ENSG00000164128 | ENSMUSG00000036437 | |||||||||
UniProt | P25929 | Q3V1K5 | |||||||||
RefSeq (mRNA) | NM_000909 | NM_010934 | |||||||||
RefSeq (protein) | NP_000900 | NP_035064 | |||||||||
Lokacija (UCSC) | Chr 4: 164.46 - 164.47 Mb | Chr 8: 69.63 - 69.64 Mb | |||||||||
PubMed pretraga | [1] | [2] |
Neuropeptidni Y receptor tip 1 je protein koji je kod ljudi kodiran NPY1R genom.[1][2]
Selektivni ligandi
Agonisti
- Neuropeptid Y (endogeni agonist)
- Peptid YY
Antagonisti
- Peptid
- BVD-10 (selektivni NPY1 antagonist)
- GR-231,118 (mešoviti NPY1 antagonist / NPY4 agonist)
- Ne-peptid
- BIBO-3304
- BIBP-3226
- PD-160,170
Povezano
- Neuropeptidni Y receptor
Reference
Literatura
- Wan CP, Lau BH (1997). „Neuropeptide Y receptor subtypes.”. Life Sci. 56 (13): 1055–64. DOI:10.1016/0024-3205(95)00041-4. PMID 9001438.
- Parker E, Van Heek M, Stamford A (2002). „Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.”. Eur. J. Pharmacol. 440 (2-3): 173–87. DOI:10.1016/S0014-2999(02)01427-9. PMID 12007534.
- Bettio A, Beck-Sickinger AG (2002). „Biophysical methods to study ligand-receptor interactions of neuropeptide Y.”. Biopolymers 60 (6): 420–37. DOI:10.1002/1097-0282(2001)60:6<420::AID-BIP10183>3.0.CO;2-W. PMID 12209475.
- Larhammar D, Blomqvist AG, Yee F, et al. (1992). „Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.”. J. Biol. Chem. 267 (16): 10935–8. PMID 1317848.
- Herzog H, Hort YJ, Ball HJ, et al. (1992). „Cloned human neuropeptide Y receptor couples to two different second messenger systems.”. Proc. Natl. Acad. Sci. U.S.A. 89 (13): 5794–8. DOI:10.1073/pnas.89.13.5794. PMC 402104. PMID 1321422.
- Rose PM, Fernandes P, Lynch JS, et al. (1995). „Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor.”. J. Biol. Chem. 270 (39): 22661–4. DOI:10.1074/jbc.270.39.22661. PMID 7559383.
- Gicquiaux H, Lecat S, Gaire M, et al. (2002). „Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.”. J. Biol. Chem. 277 (8): 6645–55. DOI:10.1074/jbc.M107224200. PMID 11741903.
- Sheriff S, F Qureshy A, T Chance W, et al. (2002). „Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected].”. Peptides 23 (1): 87–96. DOI:10.1016/S0196-9781(01)00583-6. PMID 11814622.
- Cox HM, Tough IR (2002). „Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.”. Br. J. Pharmacol. 135 (6): 1505–12. DOI:10.1038/sj.bjp.0704604. PMC 1573267. PMID 11906964.
- Uddman R, Möller S, Nilsson T, et al. (2003). „Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues.”. Peptides 23 (5): 927–34. DOI:10.1016/S0196-9781(02)00003-7. PMID 12084524.
- Cantó Soler MV, Gallo JE, Dodds RA, et al. (2002). „Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina.”. Glia 39 (3): 320–4. DOI:10.1002/glia.10107. PMID 12203398.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Berglund MM, Schober DA, Statnick MA, et al. (2003). „The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.”. J. Pharmacol. Exp. Ther. 306 (1): 147–56. DOI:10.1124/jpet.103.051227. PMID 12665544.
- Lehner B, Sanderson CM (2004). „A protein interaction framework for human mRNA degradation.”. Genome Res. 14 (7): 1315–23. DOI:10.1101/gr.2122004. PMC 442147. PMID 15231747.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). „The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”. Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Körner M, Waser B, Reubi JC (2005). „High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.”. Clin. Cancer Res. 10 (24): 8426–33. DOI:10.1158/1078-0432.CCR-04-0821. PMID 15623622.
Spoljašnje veze
- „Neuropeptide Y Receptors: Y1”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03.
- p
- r
- u
Drugi | Moždano specifični angiogenezni inhibitor (1, 2, 3) • Cadherin (1, 2, 3) • Kalcitonin • CALCRL • CD97 • Kortikotropin-oslobađajući hormon (1, 2) • EMR (1, 2, 3) • Glukagon (GR, GIPR, GLP1R, GLP2R) • Hormon rasta oslobađajući hormon • PACAPR1 • GPR • Latrofilin (1, 2, 3, ELTD1) • Metuselah-slični proteini • Paratiroidni hormon (1, 2) • Sekretin • Vazoaktivni intestinalni peptid (1, 2) |
---|
glutamat / feromon
Drugi |
---|
Frizzled / Zaglađeni
Uvojiti | |
---|---|
Zaglađeni |
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)